LncRNA CASC2 was found to be downregulated in the plasma of RA patients compared with its levels in the plasma of healthy controls, and lncRNA CASC2 overexpression could induce more apoptotic HFLSs by inhibiting IL-17 expression [13]. This evidence concerns the gene IL17A and rheumatoid arthritis.